Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1942-1961
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1942
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1942
Figure 6 Serum biochemical analyses and ELISA tests.
A: Effect of Buqing granule (BQKL) on total cholesterol and triglyceride levels in the serum of diabetic retinopathy (DR) rats; B: Effect of BQKL on superoxide dismutase, malondialdehyde, and glutathione peroxidase contents in the retina of DR rats; C: Effect of BQKL on oxidative stress in rat serum. The sequence from left to right represents the control group, the model group, the BQKL group and the Calcium dobesilate group. aP < 0.05, cP < 0.001. BQKL: Buqing granule; CaD: Calcium dobesilate.
- Citation: Yang YF, Yuan L, Li XY, Liu Q, Jiang WJ, Jiao TQ, Li JQ, Ye MY, Niu Y, Nan Y. Molecular mechanisms of Buqing granule for the treatment of diabetic retinopathy: Network pharmacology analysis and experimental validation. World J Diabetes 2024; 15(9): 1942-1961
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1942.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1942